Chemokine (CXC motif) ligand 16 (CXCL16) and osteoprotegerin (OPG) as predictors of outcome in patients with acute coronary syndromes (ACS) a PLATO biomarker substudy

Torill Ueland,Annika E. Michelsen,Pål Aukrust,Richard C. Becker,Maria Bertilsson,Stefan James,Agneta Siegbahn,Robert F. Storey,Lars Wallentin,F Kontny

Chemokine (CXC motif) ligand 16 (CXCL16) and osteoprotegerin (OPG) as predictors of outcome in patients with acute coronary syndromes (ACS) a PLATO biomarker substudy

2014

Torill Ueland
Annika E. Michelsen
Pål Aukrust
Richard C. Becker
Maria Bertilsson
Stefan James
Agneta Siegbahn
Robert F. Storey
Lars Wallentin
F Kontny

Chemokine (CXC motif) ligand 16 (CXCL16) and osteoprotegerin (OPG) as predictors of outcome in patients with acute coronary syndromes (ACS) a PLATO biomarker substudy

Keywords:

Cardiology
Osteoprotegerin
Internal medicine
Chemokine
Medicine
Biomarker (medicine)
CXCL16
Diabetes mellitus
Immunology
Oncology
in patient

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations